Nutrient withdrawal rescues growth factor-deprived cells from















































































































































cascades  linking  energy  dysmetabolism  to  cell  damage  and  loss  are  still  incompletely  clarified,  and  novel  molecular
paradigms and pharmacological targets critically needed. We provide evidence that in the retrovirus‐packaging cell line
HEK293‐T Phoenix, massive cell death in serum‐free medium is remarkably prevented or attenuated by either glucose or






event  was  affected  by  overexpression  of  the  NAD+  dependent  deacetylase  Sirt‐1,  another  cellular  sensor  of  nutrient
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Mammalian cells sense availability of nutrients through 
a complex array of both paracrine/endocrine and cell-
autonomous signaling cascades which regulate 
proliferation, differentiation and survival. Deregulated 
function of these cascades either due to nutrient excess 
or abnormal cell responses, play a central role in 
metabolic diseases such as diabetes and its 
complications [1,2], in body ageing [3] and cancer [4,5]. 
A better understanding of the molecular interactions 
underlying cellular consequences of exposure to energy 
substrates is therefore key to the understanding, the 
prevention and the therapy of severe and 
epidemiologically relevant human diseases. 
 
The mTOR (mammalian Target of Rapamycin)/FRAP 
cascade serves a unique function in coordinating 
nutrient availability and energy metabolism with cell 
response to growth factors [6,7]. By phosphorylating 
and activating the S6 kinase or inhibiting the Elongation 
Factor 4 Binding Protein-1 (4EBP-1), mTOR stimulates 
the ribosomal translation of different classes of mRNAs, 
thereby promoting protein synthesis. It also acts directly 
on gene expression by phosphorylating transcription 
factors mainly involved in the orchestration of glucose 
and lipid metabolism [7]. Accordingly, mTOR activity 
is exquisitely sensitive to cell energy status, sensed 
through a complex circuitry involving the AMP-
activated kinase, a serine threonine kinase activated by 
the reduction of intracellular ATP and the increase of 
AMP/ATP ratio [8]. Phosphorylation of the 
TSC1/TSC2 complex by AMPK and the consequent 
inactivation of the GTPase Rheb, an upstream activator 
of mTOR, profoundly inhibits mTOR signaling, thereby 
reducing protein synthesis and promoting cell survival 
under nutrient restriction [8]. mTOR is also directly 
regulated by aminoacids, through a distinct mechanism 
involving the GTPase Rag [9]. Finally, the mTOR 
cascade is crucial for signaling downstream of growth 
factor receptors including the insulin receptor. It is in 
fact, activated, in a TSC- and Rheb-dependent fashion, 
by growth factors through PI3 kinase and the serine-
threonine kinase AkT/PKB [10].  Consequently, the 
mTOR cascade integrates nutritional and 
mitogenic/antiapoptotic cues ensuring that energy 
supply and protein synthesis are adequate to support cell 
growth (i.e. increase in cell size), proliferation, and 
accumulation of biomass. 
 
Most of nutrient-related functions of mTOR are 
mediated by a multimolecular complex including 
mTOR itself and the scaffold protein Raptor (a complex 
indicated as TORC1) [11]. Nonetheless, additional 
mTOR signaling capacity directed towards AkT/PKB 
also involves a second, largely nutrient- and rapamycin-
insensitive complex (TORC2) centered on Rictor as 
main scaffold component [12]. Thus, mTOR operates 
both upstream and downstream of PKB/AkT, revealing 
an intricate cross-talk with PKB-dependent survival and 
mitogenic signaling at the intersection between cell 
metabolism and regulation of normal tissue growth. 
 
Hyperactivation of the mTOR/S6K axis has recently 
drawn significant attention as a key factor in the 
establishment of obesity and insulin resistance by 
nutrient overload [13]. S6K deficient mice display 
increased life span and resistance to age-related 
pathologies including loss of insulin sensitivity[14] 
Moreover, mTOR hyperactivation by excess nutrients 
negatively influences, both in vivo and in vitro, insulin 
and growth/trophic factor signaling, through the feed-
back inhibition of upstream components such as the 
Insulin receptor Substrate 1 (IRS-1) [13, 15-17]. 
Finally, it has been demonstrated that mTOR activation 
leads to cell senescence in the context of block of the 
cell cycle [18], and, more in general, evidence exist that 
the mTOR cascade may play a central role in the 
signaling derangement that underlies tissue and body 
ageing [19].  
 
Hence, converging lines of evidence indicate that 
mTOR and its downstream pathway, by transducing 
nutrient-triggered signals, may mediate cellular damage, 
through molecular mechanisms largely involving 
mTOR cross-talk with growth factor-triggered 
mitogenic and survival cascades. 
 
Here we report a novel mechanism for cell survival 
regulation by nutrients. In particular, our findings reveal 
that unbalanced mTOR activity in the absence of 
adequate growth factor supply, may represent a general 
mechanism of cell death by excess nutrients. This may 
be relevant in the study of tissue hyperglycemic 
damage, in body senescence and cancer therapy, 
prospectively suggesting a possible pharmacological 




Nutrient restriction protects 293T Phoenix cells from 
death by serum deprivation 
 
Most immortalized cell lines undergo mitotic 
catastrophe and cell death with morphological and 
biochemical features of apoptosis when deprived of 
fetal calf serum or growth factor supply [20]. Upon 
serum withdrawal, 293-T Phoenix  cells, a retrovirus 
packaging line derived from E1A-transformed 
embryonic human kidney cells (HEK-293) carrying a 
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time-dependent loss of viability, as revealed by a 
Propidium Iodide uptake assay (Figure 1A). Nearly 
100% of cells appeared dead by day 4 of culture (96 
hours) (Figure 1A). Remarkably, removal from the 
culture medium of either Glucose or Aminoacid 
Supplement (Glutamine + DMEM Non Essential 
Aminoacids), the two main energy fuels for most 
cultured transformed cells [21], resulted in a drastic 
protection from cell death. Typically we detected a 
maximum of mortality of up to 30% at day 4 under 
glucose deprivation, and below 10%, comparable to 











































for aminoacid-starved cultures.  Reduction of glucose 
from high (4.5 g/l) to low (1 g/l) concentration had no 
significant effect on cell viability, indicating that even 
physiological concentrations of glucose promote death 
of Phoenix cells in the absence of serum. Simultaneous  
removal of glucose and aminoacid supplement from the 
culture medium resulted in rapid (12 hours) loss of 
viability, in a fashion which could not be prevented by 
addition of Pyruvate, Dimethyl-Succinate or Free Fatty 
Acids (not shown); this confirms that glucose and 
glutamine account for most of the energy supply for 
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proliferating robustly in the absence of serum, and are 
therefore, at least in part, self-sufficient for mitogenic 
stimulation. Cell proliferation and death appear to occur 
concomitantly (Figures 1A and 1C), and are likely to be 
mechanistically linked [22]. Proliferation also occurred, 
although to a lesser extent, in nutrient deprived cultures, 
yet associated with no or minimal cell loss (Figures 1A 
and 1C). 
 
Beneficial effect of nutrient restriction on cell viability 
prompted us to evaluate the consequence of 
pharmacological interference with cellular metabolism. 
As expected, the glycolysis inhibitor 2-deoxyglucose 
fully rescued cells from death in the presence of 
glucose, to an even larger extent than glucose 
deprivation (Figure 1B). Similarly, significant 
protection was obtained by interference with 
mitochondrial respiration: in fact, both complex I 
inhibitor Rotenone and complex II inhibitor 3-
Nitropropionic acid (NPA) drastically reduced death of 
serum-deprived cultures. Also the uncoupling agent 2,4-
dinitrophenol(2,4-DNP), at non toxic concentration, had 
the same protective effect as mitochondrial inhibitors on 
cell survival in 2 g/l glucose (Figure 1B); noteworthy, 
both DNP and electron transport chain (ETC) blockers 
rapidly killed Phoenix cells in the absence of glucose 
(not shown), indicating that mitochondria are functional 
in this cell line and support energy demand when 
glycolysis is prevented. 
 
In order to evaluate the impact of nutrient restriction on 
the energy balance of Phoenix cells, ATP content was 
measured 48 hours after cell transfer to the different 
culture media. As expected based on survival data, no 
drastic reductions in cellular ATP levels were observed 
upon nutrient withdrawal (Figure 1D). Glucose 
deprivation led to a modest (about 20%) decrease of 
cellular ATP, and aminoacid removal to no reduction at 
all, compared to standard growth medium (2 g/l glucose 
and aminoacid supplement). ATP reduction was more 
pronounced (about 50%) in cells treated with Rotenone 
(Figure 1D), indicating that mitochondria contribute 
significantly to ATP generation in this tumor cell line. 
Thus, survival of Phoenix cells in serum free medium is 
clearly subdued to a metabolic regulation by nutrient 
availability, that operates independently from severe 
changes in cellular energy levels. 
 
Nutrient toxicity in serum-deprived Phoenix cells is 
not mediated by ROS 
 
Cell death by serum withdrawal is associated with the 
formation of harmful reactive oxygen species (ROS) 
[20], and nutrients may generate ROS through their 
oxidation in mitochondria [23]. Since nutrient 
restriction or mitochondrial blockade rescued Phoenix 
cells from serum deprivation, we tested possibility that 
cell protection might be mediated by an attenuation of 
cellular oxidative stress. To this end, Phoenix cells were 
transiently transfected with a redox-sensitive variant of 
the yellow fluorescent protein (rxYFP) and the 
intracellular redox state evaluated by confocal 
microscopy and fluorescence ratiometric analysis, 24 
hours after serum or serum and glucose deprivation. 
RxYFP consistently appeared more reduced (as 
indicated by higher values of the Ratiometric Index R) 
in glucose-fed than in glucose-starved cells, revealing 
significantly higher levels of ROS in the latter cell 
population (Figures 2A, a and b). This finding was 
further supported by evidence of higher content of 
reduced NAD(P)H in glucose-fed cultures, as 
determined by cell microfluorimetry (Figure 2A, c). No 
significant redox changes were observed in cells 
deprived of Glutamine and NEAA or exposed to the 
mTOR inhibitor Rapamycin. As expected, addition of 
FCS further reduced the intracellular environment in 
glucose-fed cells (Figure 2A, b). 
 
Based on these findings, excess oxidative stress 
unlikely accounts for impaired cell viability by 
nutrients. In keeping with this conclusion, no major 
changes in cell viability were induced, in the presence 
or absence of glucose, by saturating concentration of 
the ROS scavenger and glutatione precursor N-
acethyl-cysteine (NAC, 10 mM) (Figure 2B, a). 
Similarly, overexpression of the ROS scavengers 
Catalase (Figure 2B, a) and SOD2 (Figure 2C and 2D, 
b) did not provide glucose-fed cells protection from 
death, nor affected cell viability in glucose free-
medium. Notably, overexpression of Catalase 
effectively increased cell antioxidant capacity, as 
revealed by flow cytometry of cells loaded with the 
redox-sensitive dye Dichlorofluoresceine Diacetate 
(H2-DCF-DA) and exposed to a bolus of exogenous 
hydrogen peroxide (Figure 2B, b). Finally, 
overexpression of the class III deacetylase Sirt-1, a 
molecule linking, in model organisms and in 
mammalian cells, nutrient restriction to increased 
resistance to oxidative stress [24], did not rescue cells 
from glucose-induced death in serum-free medium 
(Figures 2C and 2D, a). Thus, collectively, these data 
suggest that generation of ROS and oxidative stress do 
not mediate the effects of glucose on cell viability in 
our experimental model. Additionally, failure of 
Sirtuin-1 to prevent or attenuate glucose-induced cell 
death indicates that this major nutrient sensor and 
regulator of cell survival is unlikely involved in the 
protective response of Phoenix cells to nutrient 
restriction.  
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death 
 
Since glucose and aminoacid withdrawal provided 
comparable protection to serum-starved Phoenix cells, 
in spite of having different effects on cell energy 
(Figure 1D) and redox balance (Figures 2A and B and 
data not shown), we reasoned that a common signaling 
mechanism might underlie the antiapoptotic action of 
the two starvation modes. The mTOR/S6K signaling 
cascade, which is modulated by both glucose and 
aminoacids and regulates cell proliferation and survival 
[6], was therefore evaluated as a potential candidate. 
 
Even in the absence of exogenous growth factors, 
mTOR activity remained remarkably elevated in 
glucose-fed cells 24 hours after serum withdrawal, as 
revealed by the phosphorylation patterns of the major 
mTOR effectors S6 kinase and 4E-BP1, and of the 
downstream substrate S6 (Figure 3A, lane 1). Note that 
in this analysis phospho-site specific antibodies often 
recognize multiple bands, the uppermost, slowest-
































phosphorylated form of the protein (see arrows) [25]. 
Based on this criterion, we observed a marked reduction 
of mTOR activity in glucose-starved, and to an even 
larger extent, in aminoacid-starved cells (Figure 3A, 
lanes 2 and 3). A drastic reduction in S6 kinase 
phosphorylation was also observed in glucose-fed cells 
treated with mitochondrial inhibitors or with the 
uncoupler 2,4-DNP, in keeping with the starvation-
mimicking effects of these treatments on cell survival 
(Figures 3B and 1C). In glucose-starved cells we also 
observed a small increase in the phosphorylation of the 
AMP-activated protein kinase (AMPK-α) (Figure 3A), 
the putative negative regulator of mTOR in this 
experimental condition [8]. This modest, although 
detectable biochemical change, which reflects the small 
reduction in cellular ATP content reported in figure 1 D, 
likely accounts for reduced mTOR signaling (Figure 
1B) [8]
  in  Phoenix cells grown in the absence of 
glucose. Thus, collectively, these observations confirm 
that mTOR is responsive to glucose and aminoacids, 
and that its activity positively correlates with nutrient 













































www.impactaging.com                  492                                          AGING,   August 2010, Vol.2 No.8In order to address the role of the mTOR/S6K cascade 
in nutrient-dependent death of Phoenix cells, we 
evaluated the effect of mTOR blockade on cell viability 
in standard and glucose-depleted medium. Rapamycin, 
a macrolide antibiotic widely used as an 
immunosuppressive drug, directly inhibits mTOR 
activity within the nutrient sensitive TORC1 complex, 
by complexing with the cellular protein FKBP12; 














































nucleoside (AICAR), indirectly suppresses mTOR 
signaling through AMP kinase, by mimicking cell de-
energization and accumulation of adenosine mono-
phosphate (AMP) [26]. As expected, both drugs 
drastically decreased the phosphorylation of the mTOR 
substrate S6 kinase in cells grown in the presence of both 
glucose and aminoacids (Figure 4A). More importantly, 
both Rapamycin and AICAR dramatically reduced cell 























































glucose  without  glutamine  and  NEAA).  In  the  anti  p‐S6K  and  anti  p‐4EBP1  a  selective  loss  of  the  slow  migrating,
hyperphosphorylated  band  by  nutrient‐repleted  sh‐mTOR  samples  can  be  appreciated.  (D)  Survival  assay  displaying
reduced  mortality  of  sh‐mTOR  transduced  Phoenix  cells  in  serum‐free,  nutrient  repleted  medium.  Note  that  nutrient‐




www.impactaging.com                  493                                          AGING,   August 2010, Vol.2 No.8In order to rule out potential non-specific effects of 
drug compounds, in a parallel series of experiments 
mTOR expression in Phoenix cells was genetically 
inactivated by shRNA technology. As displayed in 
figure 3C, lentiviral expression of a mTOR specific 
shRNA resulted in a substantial reduction of the 
mTOR expression level, and in a reduced 
phosphorylation of its downstream targets S6K, S6 and 
4E-BP1, in nutrient-rich samples (Figure 4C, compare 
lanes 1 and 4 in each panel). In keeping with evidence 
of cell protection by Rapamycin and AICAR, mTOR 
inactivation allowed a higher percentage of cells 
(about 50%) to survive in nutrient repleted medium 









































ed protection by glucose withdrawal (Figure 4D). It 
should be noted, however, that here and in general in 
experiments involving genetic manipulation of 
Phoenix cells, mortality in the absence of nutrients was 
often higher than the usual (compare Figure 1A with 
4D and S2,a), possibly due to cellular distress from the 
experimental procedure. Notwithstanding this 
limitation, survival data with mTOR-silenced cells 
confirm the observations made with chemical 
inhibitors, demonstrating that activation of the mTOR 
cascade is instrumental to nutrient-triggered cell death 
in the cell line under study, and that protection by 
nutrient restriction is conceivably mediated by the 
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account for cell protection  
 
While in most cancer-related models the mTOR cascade 
exerts antiapoptotic functions downstream of the PI3 
kinase/AkT PKB signaling axis [27], few examples of 
cell protection by inhibition of mTOR/S6K have been 
reported [28-31]. It is also known that hyperactivation 
of the mTOR cascade can downregulate survival 
signaling by the AkT/PKB kinase [15, 16]. In search for 
a molecular mechanism linking nutrient-dependent 
mTOR signaling to massive cell death of serum-
deprived  Phoenix cells, we sought to evaluate the 
phosphorylation of AkT at serine 437, a biochemical 
correlate of AkT kinase activity. Consistent with 
previous reports, we found increased levels of AkT 
phosphorylation/activity in cells deprived of glucose or 






































correlated with the activation of the mTOR effector S6 
kinase (Figure 5 A, a). mTOR-silenced cells also 
displayed increased phosphorylation of AkT in 
nutrient rich medium, although to a lower extent 
compared to control cells treated with Rapamycin 
(Figures 5A, a and b); moreover, transfection of rat 
mTOR cDNA in cells deprived of human mTOR 
rescued mTOR expression and activity (as assessed by 
phosphorylation of S6) and in parallel decreased the 
phosphorylation of AkT (Supplementary data, S1). 
Thus, taken together, these observations confirmed 
that, in serum-deprived Phoenix cells, nutrients 
downregulate AkT phosphorylation/activity through 
the mTOR cascade. This raises the possibility that 
increased AkT function might be responsible, at least 
in part, for the dramatic protection provided by 

















































www.impactaging.com                   495                                          AGING,    August 2010, Vol.2 No.8To further investigate the mechanistic role of the PI3K-
AkT cascade in cell survival induced by nutrient 
deprivation, cells were treated with the PI3 kinase 
specific inhibitor LY294002, and exposed to normal or 
glucose-deprived media in the absence of serum. 
Surprisingly, the PI3K inhibitor failed to reverse cell 
protection by glucose withdrawal, but attenuated cell 
death in nutrient-repleted medium (Figure 6A, a), 
suggesting that residual AkT activity may be 
detrimental rather than protective in this culture 
condition. Interestingly, biochemical studies revealed 
that, while AkT/PKB phosphorylation was, as expected, 
decreased, also the serine phosphorylation of S6 was 
strongly downregulated. This is an evidence that 
inhibition of the mTOR cascade, a downstream target of 
AkT [10], accompanied PI3K blockade (Figure 6A, b).  
 
In a complementary series of experiments, over-
expression of a constitutively active form of AkT 
(myrAkT) in Phoenix cells failed to prevent cell death 
in nutrient rich medium, while slightly decreasing cell 
protection by glutamine withdrawal (Supplementary 
Figure S2).  
 
Collectively, these data do not support a role for AkT in 
cell survival by nutrient restriction in our cell model, 
but rather indicate that protection operates also in the 
context of PI3K (and AkT) inhibition, provided that the 
mTOR cascade is also blocked. Conversely, AkT 
appears to increase cell death in the presence of 
abundant nutrients, and to negatively interfere with cell 
protection by Glutamine deprivation.  
 
mTOR inhibition attenuates hyperglycemic damage 
in primary endothelial cells 
 
In an attempt to verify that mTOR-dependent nutrient 
toxicity is not restricted to one single transformed cell 
line, we cultivated primary human endothelial cells 
(HUVEC) in high (4.5 g/L) ambient glucose, a well 
established model of endothelial hyperglycemic 
damage. Specific endothelial growth factors (EGF, 
FGF-B, VEGF and IGF-1), normally required for the 
optimal propagation of these cells, were omitted from 
the culture medium, while FBS (5%) was included to 
limit cellular stress. In these harsh conditions, a 
majority of cells detached from the plate and appeared 
dead after 48-60 hours of incubation, the percentage of 
live cells (quantified by flow cytometry as the 
percentage of cells with high forward scatter, low side 
scatter profile) ranging from 10 to 15%. Cell survival, 
however was significantly improved (nearly doubled) 
by Rapamycin, to an extent even larger than by 
cultivation in normal (0.9 g/L) glucose (Figure 6A, a). 
Importantly, these differences matched the phospho-
rylation level of S6, an index of mTOR activity (Figure 
6B). Likewise, mTOR knock-down by lentivirus-
delivered shRNA consistently increased cell survival by 
about 20%, in accordance with the evident although 
incomplete inhibitory effect on mTOR signaling 
(Figures 6A, a and 6B). 
 
Additionally, accumulation of O-GlcNacylated proteins, 
a biochemical hallmark of endothelial damage by high 
glucose [2, 32], was drastically reduced by Rapamycin 
and, although to a lesser extent, by mTOR knock-down 
(Figure 6B). 
 
Thus, inhibition of the mTOR cascade partially rescues 
primary human endothelial cells from hyperglycemic 
damage under growth factor restriction, confirming and 




We describe here a novel mechanism for cell survival 
regulation by nutrients, our major conclusion being that 
activation of the mTOR signaling pathway is 
detrimental to cell survival in the context of growth 
factor scarcity. This conclusion is mainly based on 
mechanistic studies performed on a widely used tumor 
cell line, but has also been validated using a cell model 
(human primary endothelial cells) relevant to nutrient-
related pathologies like vascular ageing and diabetic 
complications. 
 
We have shown that, in the absence of exogenous 
growth factors, the 293-T “Phoenix” retrovirus 
packaging cell line undergoes massive cell death in a 
fashion strictly dependent on the availability of 
nutrients in the growth medium. In particular, with 
respect to a normally supplemented medium containing 
both glucose (either 4.5 g/l or 1 g/l), and glutamine + 
non essential aminoacids, withdrawal of either 
supplement exerts a remarkable protective effect with a 
nearly complete rescue of the culture, at least in the 
considered time frame (3-4 days). Importantly, although 
not investigated in detail, morphological data and flow 
cytometry evidence of subdiploid DNA accumulation 
and high side-scattering cell profiles (not shown) clearly 
suggest that nutrient-induced death of Phoenix cells 
largely occurs by apoptosis. 
 
From a biochemical point of view, we have clearly 
demonstrated the involvement of the nutrient sensor 
mTOR in the protective cell response to nutrient 
restriction, and investigated its complex relation with 
the PI3 kinase/AkT signaling cascade. In view of the 
growing attention towards the mTOR/S6K cascade as a 
signaling module at the crossroad of multiple 
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cancer, the observation that mTOR inhibition mediates 
the cell protective effect of nutrient withdrawal adds 
special value to our observation. 
 
Cell damage by excess nutrient contributes to important 
pathologic conditions including Metabolic Syndrome, 
insulin resistance and diabetic micro- and macro-
angiopatic complications. In a current model for 
hyperglycemic vascular damage, multiple pathogenic 
mechanisms (including deregulation of the polyol and 
hexosamine pathways and hyperactivation of PKC) are 
triggered in endothelial cells by glucose-driven 
overproduction of reactive oxygen species [2]. Our 
results significantly diverge from this model: first of all, 
death of Phoenix cells in high nutrients does not seem to 
involve Reactive Oxygen Species, although 
mitochondrial inhibitors, but not antioxidants, provide a 
significant protective effect. Second, not only 
hyperglycemia, but also physiological (5 mM) 
concentrations of glucose appear “toxic” in our model, 
in presence of glutamine/aminoacids. On the other 
hand, removal of nutrients from the culture medium has 
no gross effect on cell energy balance, based on ATP 
measurements displayed in figure 1 D. We therefore 
favor the idea that a fine signaling mechanism, sensitive 
to physiological levels of both nutrients (glucose and 
aminoacids) as well as to mitochondrial dysfunction 
[33], regulates cell survival in our experimental setting; 
this mechanism has been identified in the activation of 
mTOR and his downstream cascade. 
 
Experiments on HUVEC cells have been performed to 
test the relevance of the above mechanism in a more 
physiological context. These experiments have 
confirmed that the mTOR cascade contributes to 
endothelial damage by the combination of excess 
nutrients and growth factors scarcity, although with 
some differences between the two cell models. In 
particular, base-line mortality is higher and in part 
nutrient-insensitive in endothelial cells, and, as a 
consequence, effects of mTOR blockade on cell 
survival less dramatic. Conversely, drastic changes in 
GlcNAcylated protein accumulation in response to 
ambient glucose or mTOR functional status have been 
difficult to demonstrate in Phoenix cells (not shown). 
Notwithstanding these incongruencies, studies on 
endothelial cells strengthen, on one side, the role of 
mTOR in glycotoxicity, and underscore, on the other 
side, the potential of the Phoenix cell model in 
recapitulating important biochemical aspects of 
nutrient-related human pathology. 
 
The downstream molecular events linking inhibition of 
mTOR (TORC1) to cell survival in the presented cell 
models needs further investigation. Although evidence 
of increased AkT phosphorylation/activation in cells 
deprived of nutrients or subdued to mTOR blockade 
represented an attractive candidate mechanism, our 
findings in Phoenix cells did not support this 
conclusion. In fact, a) cell survival by nutrient 
deprivation was not reverted by the PI3K inhibitor 
LY294002, and conversely, b) cell death in the presence 
of nutrients was actually attenuated by AkT/PKB 
blockade, while overexpression of AkT slightly 
decreased rescue by glutamine deprivation. Instead, 
since protection by Ly294002 in nutrient-rich medium 
(Figures 5B, a and S2) occurred in parallel with 
inactivation of the mTOR cascade (Figure 5B, b), these 
findings reinforce the idea that 1) mTOR signaling is 
absolutely critical for cell death in this experimental 
context, and 2) that beneficial effect of mTOR occurs 
also in the context of nearly complete AkT inhibition. 
 
Interestingly, the detrimental action of the PI3K/AkT 
cascade on Phoenix cell survival, as suggested by data 
in figure 5 and S2, while rather unusual for a cancer cell 
line, is instead reminiscent of genetic evidence from 
model organisms, whereby PI3K inhibition promotes 
resistance to stress and longevity [34]. 
 
Other mechanisms for the protective effect of mTOR 
inhibition can be envisaged and deserve experimental 
verification.  
 
First, inhibition of mTOR may protect cells by arresting 
cell cycle and preventing inappropriate G1/S transition, 
in the absence of growth/survival factors. Growth 
curves displayed in figure 1 B showing reduced but not 
arrested proliferation by nutrient restriction, partially 
support this possibility. P53, which is involved in a 
metabolic checkpoint induced by cell energy depletion 
[35], unlikely participates in cell cycle regulation in our 
model, since this tumor suppressor protein is 
functionally inactivated in Phoenix cells by the large T 
antigen. Instead, another metabolic checkpoint triggered 
by mitochondrial damage and accumulation of oxygen 
radicals, recently  described in Drosophila  [36], is 
compatible with our finding of increased ROS in 
glucose- deprived Phoenix cells (Figure 2).  
 
Second, attenuation of ER stress [37], and induction of 
autophagy [38] may also contribute to cell protection by 
inhibition of the mTOR cascade in our cellular models. 
In fact, of the few reported examples of mTOR pro-
apoptotic activity, most refer to conditions in which ER 
stress can be demonstrated or at least suspected [29-31, 
37]. Along similar lines, autophagy exerts important 
antiageing effects in model organisms and prevents cell 
damage by accumulation of misfolded proteins or 
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above outlined is therefore warranted. 
 
Likewise, further effort is required to validate the above 
described, mTOR dependent circuitry of metabolic 
toxicity in tissues directly involved in nutrient-related 
pathology. While initial experiments performed on 
endothelial cells encouragingly point to this direction, 
(Fig 6), peripheral nerves and pancreatic beta cells 
definitely deserve to be investigated. 
 
In conclusion, we have presented novel evidence for a 
negative regulation of cell survival by excess nutrients 
through the mTOR pathway. If confirmed, and 
extended, these observations may have important 
theorethical implications for the molecular under-
standing of the ageing process, and significant impact 
on the prevention and treatment of important nutrient- 
and aging-associated diseases like type II diabetes and 
its complications. 
 
Additionally, we have shown that HEK-293T Phoenix 
cells, an easy-to-handle and highly genetically 
manipulable cell line, can represent a valuable tool for 
mechanistic studies and pharmacological screenings 
related to nutrient-dependent cell damage, and by 




Reagents, antibodies, plasmids and cell lines. Chemicals 
were purchased from Sigma-Aldrich (Milan, Italy) 
unless differently stated. Rapamycin was from LC 
Laboratories (Woburn, MA), LY294002 from Cayman 
Chemical Company (Ann Arbor, MI). The redox-
sensitive dye H2-Dichlorofluorescein Diacetate (H2-
DCF-DA) was obtained from Invitrogen s.r.l. (San 
Giuliano Milanese, Italy).  
 
The following primary antibodies were used: anti 
sir2/Sirt1 (rabbit polyclonal, cat.# 09-844) and anti 
SOD2 (rabbit polyclonal, cat.# 06-984) from Upstate 
Biotechnology/Millipore (Vimodrone, Milan, Italy); 
anti-actin (goat polyclonal, cat #sc-1615 and sc-1616), 
anti S6 kinase 1 (rabbit polyclonal, C18, sc-230), and 
anti mTOR/FRAP (rabbit polyclonal, C19-R, cat.# sc-
1550-R) from Santa Cruz Biotechnology Inc. 
(Heidelberg, Germany); anti p-S6K1, Thr 389 (cat# 
9205); anti p-S6, Ser 235-236 (cat#2211); anti p-
4EBP1, Thr 37-46, (cat# 2855P); anti p-AMPK α, Thr 
172, (cat# 2531); anti phosho-(Ser 437) AkT, (cat# 
9271); anti AkT, (cat# 9272); anti p-GSK3-β, Ser-9, 
(cat# 9336), all from Cell Signaling Technology 
(Danvers, MA). HRP-conjugated goat anti rabbit IgG 
antiserum was from BIORAD (Segrate, Milan, Italy).  
The plasmid encoding the human Sirt-1 cDNA in the 
pBabe Puro vector backbone was kindly provided by 
Dr. Michael Greenberg (Harvard Medical School, 
Boston, MA). Expression constructs for rat mTOR 
(pcDNA3 vector, Invitrogen) and human Catalase 
(pLNCX vector, Clontech, Mountain View, CA) were a 
gift of Dr. Toren Finkel (NHLBI, NIH, Bethesda, MD). 
The construct encoding a myristoylated, constitutively 
active mutant of human AkT fused to the Estrogen 
Receptor ligand binding domain (Myr(Δ1-129)-AkT-
HA-ER) in the pWZL-hygro retroviral vector [27] was 
provided by Dr. Barbara Bedogni (University of 
Stanford, CA). 
 
The pcDNA3-based construct encoding human SOD2 
was described elsewhere [39]. Mission™ shRNA clones 
constructed within the lentivirus plasmid
  vector 
pLKO.1-Puro were purchased from Sigma Aldrich 
(Milan, Italy). 
 
293-T Phoenix cells, a retrovirus packaging line derived 
from E1A-transformed embryonic human kidney cells 
(HEK-293) carrying a temperature sensitive T antigen 
[40], were kindly provided by Dr. G. Nolan (University 
of Stanford, CA). A detailed description of this cell 
derivative can be found in the Nolan’s Laboratory 
Home Page (http://www.stanford.edu/group/nolan/ 
retroviral_systems/phx.html). 
 
Cells were routinely maintained in Dulbecco’s Modified 
Eagle’s Medium (DMEM) containing 4.5 g/l glucose, 2 
mM Glutamine, 1 mM Sodium Pyruvate, Non Essential 
Aminoacids and Penicillin-Streptomycin (EUROBIO, 
Les Ulis, France). 
 
Human Umbilical Vein Endothelial Cells (HUVEC) 
were obtained from Lonza/Clonetics® (Walkersville, 
MD, USA) and maintained in EBM-2 Basal Medium 
supplemented with hEGF, VEGF, B-FGF, IGF-1, 
Hydrocortisone, Heparin, Acorbic Acid, Gentamicin, 
Amphotericin B and 2% FBS (EGM-2 Bulletkit, Lonza, 
CC-3162). For experimental procedures cells between 
passages 4 and 7 were used. 
 
Cell viability assay. Phoenix Cells were seeded at 10
5 
cells/well, in 24-well plate in complete medium and 
incubated for 16 to 24 hours. Medium was then replaced 
with glucose-free/glutamine-free DMEM (Eurobio) 
(basic formulation as reported in supplemental table 1), 
1 mM Pyruvate, Penicillin-Streptomycin and 1 mM 
HEPES pH 7.4. When necessary the medium was 
supplemented with serum (or Bovine Serum Albumin, 
BSA), glucose, glutamine and Non Essential 
Aminoacids (NEAA, formulation of the 50X solution in 
supplemental table 2). Pharmacological inhibitors were 
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2-deoxyglucose (2-DG), 10 mM; Rapamycin, 200 nM; 
Ly294002, 20 μM; Rotenone, 5 μM; 3-nitropropionic 
acid (3-NPA), 1 mM; 2,4 Dinitrophenol, DNP, 1 mM; 
N-Acetyl Cysteine (NAC) 10 mM. After 72-96 hours 
incubation (humidified incubator, 37°C, 5% CO2) live 
and dead cells were collected by gentle pipetting and 
transferred into dedicated vials for flow cytometry 
(COULTER Epics, 480 nm Argon laser lamp). 
Immediately before analysis Propidium Iodide was 
added at 1 μg/ml. PI-positive cells (FL-3) were scored 
as dead cells after threshold definition with unstained 
cells; cell debris was gated out and excluded from the 
analysis [41].   
 
HUVEC cells were seeded in 12 well plates at 10
5 
cells/well in complete medium, and left to adhere for 12 
hours. Medium was then replaced with glucose-free 
DMEM containing 5% FBS but no specific endothelial 
growth factor, and D-glucose was added from a 300 
mM stock (in PBS) at the desired dilution. Rapamycin 
was added at 200 nM at this stage and 24 hours later, 
without medium change. 
 
After 48-60 hours of incubation cells were trypsinized, 
pooled with floating cells and analysed by flow 
cytometry, as described in reference 21. Live and dead 
cells were identified based on the position on the 
forward scatter-side scatter plot, and the % of cell 
survival calculated by the formula live cells/(live 
cells+dead cells). 
 
Cell proliferation assay. Cells were seeded at 10
4 
cells/well, in 24-well plate in complete medium. 16-24 
hours later medium was replaced with glucose or 
glutamine-free DMEM without FBS. Live cells from 
triplicate wells were counted at different time-points (0, 
24, 48 and 72 hours) by an hemocytometer; dead cells 
were excluded based on morphology and trypan blue 
uptake. 
 
Cell transfections.  Transient transfections of Phoenix 
cells were made with the EFFECTENE reagent 
(QIAGEN, Hilden, Germany), directly in 24 well plate, 
using about 150 nanograms DNA/well. A master 
transfection mix for 6 wells typically contained 1 μg 
DNA, 4 μl of Enhancer and 10 μl of transfection 
reagent, according to the manufacturer’s indications 
with minor changes. Transfection efficiency was 
routinely above 50% in these conditions, based on flow 
cytometry of cells transfected with a GFP expressing 
plasmid. After 24-36 hours cells were used for survival 
assay or biochemical analysis (see below). 
 
Lentiviral-mediated RNA interference. Recombinant 
vesicular stomatitis virus
 (VSV)–pseudotyped lentiviral 
vectors were obtained by standard procedure, according 
to Tiscornia et al. [42]. Briefly, 293 T
 human embryonic 
kidney cells were co-transfected by calcium phosphate 
with the lentiviral packaging
 (pMDLg/RRE), envelope 
(pMD2.G), and rev-expressing (pRSV-REV) plasmids, 
together with the pLKO.1-based short hairpin constructs 
specific for mTOR (TRCN0000038677) or the 
Mission™ non-target control vector. Viral supernatants 
were collected 48  hours after
  transfection, filtered 
through 0.22-µm pore nitrocellulose
 filters, concentrated 
by ultracentrifugation at 50,000 x g for
 140 min at RT 
and stored at –80  C until use. Target cells were 
transduced with the lentiviral vector stocks in presence 
of 6 µg/ml Polybrene and selected using puromycin-
containing medium. 
 
Confocal analysis of cell oxidation and intracellular 
NAD(P)H. Cells were seeded in 35 mm glass bottom 
dishes (Ibidi, Integrated Biodiagnostic, Martinsried, 
Germany) and transfected with 0.75 µg of a construct 
encoding the redox-sensitive Yellow Fluorescent 
Protein (mt-rxYFP). After 48 hours cells were deprived 
of serum and nutrients for additional 24 hours, and 
fluorescent cells imaged and quantified by confocal 
microscopy (Leica, DM-IRE2 Germany) as described in 
detail elsewhere [43]. Briefly, fluorescence signals of 
samples excited at 488 nm (F488) and at 458 nm (F458) 
were measured and the ratio (F = F488/F458) calculated. 
Values of F for completely reduced (Fred) and 
completely oxidised (Fox) rxYFP were obtained from 
literature [44]. Pseudocolor images were constructed 




and ranging between 0 (complete oxidation) and 1 
(complete reduction), by means of a dedicated software 
generated through the Labview 7.1 interface [23]. For 
image quantitation, average R values were determined 
within multiple Regions of Interest (ROIs, single cells 
or small cell clusters) for each sample, and their 
Mean±SD (n = 7 to 9) determined and utilized for 
further statistical analysis (Student t-test). In some 
experiments, after initial cell imaging in nutrient-
deficient medium, nutrients were added back and cell 
redox responses monitored for 30 minutes or longer. 
 
Intracellular NAD(P)H was measured, in the same 
experimental settings as above, by two-photon confocal 
analysis of cell green autofluorescence after two-photon 
excitation at 366 nm, as described by Patterson et al. [44]. 
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studies Phoenix cells were plated at 1.5 x 10
5/well in 
12-well plate and incubated for 16 to 24 hours in 
complete medium. The day after, cells were switched to 
DMEM without glucose, glutamine/NEAA and FCS, 
and these components were added back where 
necessary. Serum-free samples were given BSA 20 
mg/ml (stock) at the same dilution as FCS (typically 
10%, i.e. 2 mg/ml final concentration). Antioxidants 
and chemical inhibitors were also added at this stage of 
the experiment (see above, viability assay). After 24 
hours supernatants were removed and cells lysed in 100 
microliters of ice-cold lysis buffer (NaCl 150 mM, Tris-
HCl 50 mM pH 8; 2 mM EDTA) containing 1% v/v 
Triton X-100, 0.1 % v/v SDS, 1:1000 Protease Inhibitor 
cocktail (Sigma), 1 mM Sodium Orthovanadate, 1 mM 
NaF; 2 mM β-glycerophosphate. After 15 minutes on 
ice with occasional vortexing cells were spun down at 
14,000 rpm, 4°C to remove debris and unlysed cells, 
and supernatant quantified for protein content (DC 
Protein Assay, BIORAD), resuspended in 6X Laemmli 
buffer, boiled for 2 minutes and stored at –80°C or 
directly loaded onto denaturing discontinuous 
polyacrylamide gels for SDS-PAGE. Proteins were then 
electroblotted onto nitrocellulose membrane 
(PROTRAN®, Whatman, Dassel, Germany). After 
reversible Ponceau S staining to confirm protein 
transfer and equal loading throughout the lanes, 
membranes were blocked in TBS-T containing 5% skim 
milk. Antisera were added in 3% milk at the appropriate 
dilution and incubated for 16 hours on a rotating plate at 
4°C. After extensive wash in TBS-T, immuno-
complexes were visualized by incubation with HRP-
conjugated secondary reagents (BIORAD) followed by 
enhanced chemoluminescence (ECL, GE Healthcare, 
Milan, Italy) and autoradiography. In some experiments 
autoradiograms were digitalized and band intensity 
(band volume, i.e. area x mean pixel intensity) 
quantified with a dedicated software (Quantity One, 
BIORAD). Quantitation was normally not performed 
when differences displayed were immediately evident. 
Occasionally membranes were stripped in 2% SDS at 
60°C, washed, blocked and subdued to a second round 
of hybridization.  
 
For protein O-glycation and phosphorylation studies on 
HUVEC, cells were handled as for viability assays, 
except that after 24 hours of incubation supernatants 
and floating cells were removed and adherent cells 
lysed as described above. 
 
Accumulation of GlcNAcylated proteins was 
determined by immunoblotting using a specific anti O-
GlcNAc monoclonal antibody (CTD 110.6, COVANCE 
[45]).  
Catalase assay. As an indirect assessment of 
intracellular catalase activity, cells were switched to 
serum-free medium (without BSA), loaded for 30 
minutes with the redox sensitive fluorescent dye H2-
Dichlorofluorescein Diacetate (H2-DCF-DA) and 
challenged with 1 mM hydrogen peroxide for 15 
minutes. Cells were then quickly transferred to tubes for 
flow cytometry and green fluorescence (Fl-1) 
quantified. Resistance to H2O2-induced cell oxidation 
was assumed to correlate with cell capacity to degrade 
hydrogen peroxide. Extracellular catalase and the 
catalase inhibitor Aminotriazol were used to validate 
this procedure.  
 
Determination of intracellular ATP. ATP was quantified 
by chemiluminescence using a dedicated kit 
(ENLITEN
® ATP Assay, PROMEGA, Milan, Italy) 
according to the manufacturer’s recommendations. For 
each sample luminescent emission was normalized for 
total protein content, determined as described above.  
 
Statistics. Data sets (usually triplicate culture wells) 
were compared by the two-tailed Student’s t-test for 
independent samples. Threshold for statistical 
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Inorganic Salts  mg/L 
Calcium Chloride anhydrous  200.00 
Ferric(III)-Nitrate•9H2O 0.10 
Potassium Chloride  400.00 
Magnesium Sulphate anhydrous  97.70 
Sodium Chloride  6400.00 
Sodium Dihydrogen Phosphate• H2O 125.00 
Carbonate 3700.00 
Amino Acids   
L-Arginine• HCl  84.00 
L-Cystine 48.00 
L-Glutamine  0 
Glycine 30.00 
L-Histidine• HCl• H2O 42.00 
L-Isoleucine 105.00 
L-Leucine 105.00 










Choline Chloride  4.00 
Folic Acid  4.00 
Myo-Inositol 7.20 
Nicotinamide 4.00 
Pyridoxal• HCl  4.00 
Riboflavin 0.40 
Thiamine• HCl  4.00 
Other Components  
D-Glucose  0 
Phenol Red  15.00 



















































































re‐expression  in  sh‐TOR  Phoenix  cells.  Cells  were






nutrients.  a.  Survival  assay  displaying  a  slight  increase  in
mortality of glutamine‐deprived cells expressing the myrAkT‐
ER  mutant.  All  cultures  were  exposed  to  1  mM  4‐hydroxy‐






expression,  responsiveness  to  4‐OHT  and  activity  of  the
myrAkT mutant in cells grown in standard medium containing
FCS. myrAkT‐ER accumulates in response to 4‐OHT as revealed











  mg/L (50x) 
L-Arginine• HCl  6320.00 
L-Cystine 1201.00 
L-Histidine• HCl• H2O  2096.00 
L-Isoleucine 2623.00 
L-Leucine 2623.00 
L-Lysine• HCl  3625.00 
L-Methionine 755.00 
L-Phenylalanine 1651.00 
L-Threonine 2382.00 
L-Tryptophan 510.00 
L-Tyrosine 1811.00 
L-Valine 2343.00 